Objective-To observe the long-term prognosis of patients with unstable angina and select simple criteria to identify high and low risk subgroups.
Patients-All patients admitted with chest pain in whom no infarct was confirmed by subsequent electrocardiographic or enzyme changes and for whom no alternative cause of chest pain was found were studied. Unstable angina was also diagnosed if there was evidence of myocardial ischaemia in the form of previous effort angina, previous myocardial infarction, or if transient electrocardiographic changes accompanied the pain. When none of the above were present, chest pain without a known cause, was diagnosed.
Interventions-No routine intervention. Angiography and revascularisation for persistent symptoms despite medical treatment.
Outcome measures-Death or nonfatal infarction.
Results-In the 141 patients with unstable angina there were eight deaths and five non-fatal infarctions during the first eight weeks. Symptoms of increasing angina before admission were similar in all three groups and did not help predict early complications. Recurrence of pain in hospital, a rise in cardiac enzymes to less than twice the upper limit of normal, and transient electrocardiographic changes were all associated with an increased risk ofearly events. The presence ofeither abnormal enzyme activity or more than five episodes of pain in hospital identified a group of 49 in whom 11 of the 13 early events occurred. After three years, 29 of the 141 patients had died and eight had had infarctions (overall event rate 26%). Seventeen had undergone revascularisation (12%) and 51 (36%) were on antianginal treatment. Thirty six (26%) were still alive, without new myocardial infarction, and were free ofangina. In the 29 patients with chest pain without a known cause there were no early events and only one non-fatal infarction during the three year follow up.
Conclusion-When patients are admitted to the coronary care unit with chest pain not due to myocardial infarction, the history, electrocardiography and measurement of cardiac enzymes are sufficient to identify high and low risk subgroups.
Cardiologists in regional centres tend to see unstable angina as an emergency situation requiring angiography and intervention, even though there is little evidence that such action improves prognosis. The perspective from a district general hospital is, however, completely different. For more than half the patients admitted with suspected myocardial infarction the diagnosis is not confirmed and many of these patients could by some definitions be diagnosed as having unstable angina. These patients usually require only a very brief stay in hospital, and there are no immediate clinical problems in most of them. Emergency referral to a regional centre because of persistent angina when at rest is a rare event.
In 1986, after Cairns et al had confirmed the benefit of aspirin in unstable angina,' a finding previously reported in the Veterans' Administration study,2 we prospectively followed up all patients admitted to our coronary care unit in a six month period with the aim of finding the proportion ofpatients who could be considered to have unstable angina, and of identifying high and low risk subgroups. We wanted to see how many of these patients progressed over a fairly long period, and we aimed to collect data that would be useful for the design of later trials. A subsidiary intention was to see how quickly aspirin would become part of routine clinical treatment in a unit where patients are looked after by general physicians on emergency intake.
The breathlessness, collapse, or arrhythmia without chest pain, in whom both electrocardiographic and enzyme criteria were filfilled. When, in the opinion of the attending medical firm, features of the history, examination, or subsequent investigations were sufficient to make a specific non-cardiac diagnosis then non-cardiac pain was diagnosed.
After the exclusion of infarction, the label of unstable angina was given if the admission symptoms were supported by evidence of ischaemic heart disease in the form of (a) effort related angina as defined by the Rose questionnaire in the preceding four weeks; (b) a documented previous infarction (using the criteria given previously); or (c) ST-T wave changes in association with pain lasting less than 72 hours.
Three subgroups of unstable angina were selected in advance as they were considered to represent levels of increasing probability that the presenting symptoms reflected myocardial ischaemia. Patients in group 1 had a history of effort related angina but had had no evidence of previous infarction and no electrocardiographic changes with the presenting pain. Patients in group 2 had had a previous infarction but had no new changes on the electrocardiogram. Group 3 contained patients with ST-T wave changes in association with the admission pain but which persisted for less than 72 hours and who did not have a rise in enzyme activity diagnostic of infarction. Some of the patients in group 3 had also suffered a previous infarction and a proportion of patients in groups 2 and 3 had already had effort related angina.
The remaining patients were diagnosed as having chest pain withou-t a known cause. This group had no history of angina or infarction, normal electrocardiograms and cardiac enzymes, and no features to support a noncardiac diagnosis. Within two weeks of admission these patients underwent a symptom limiting treadmill exercise test according to the Bruce protocol. A positive result was defined as chest pain in association with 1 mm horizontal or downsloping ST segment depression, measured at 80 ms after the J point, or 2 mm of ST segment depression without pain.
With the exception of non-cardiac pain the above diagnostic labels were independent of the attending physicians. For the purposes of the study, patients in whom acute myocardial infarction was diagnosed were only followed up until discharge from hospital. All patients in the three subgroups of unstable angina and those with chest pain without a known cause were followed up for at least three years after discharge for the development of cardiac events. This follow up was independent of the physicians involved with management. During the three year period, myocardial infarction was diagnosed by the criteria as already described and cause of death was ascertained from death certificates, supported by a review of hospital and general practice notes. After three years a second Rose (31) 10 (26) 18 (27) GTN, glyceryl trinitrate; AMI, acute myocardial infarction.
pancreatitis, and thoracic root pain. Table 1 shows the characteristics and in hospital clinical course of patients with myocardial infarction, unstable angina, and chest pain without a known cause. During the same period, 356 patients in whom cardiac enzymes were measured were admitted to medical wards, rather than to coronary care. These patients were not followed up for the purposes of this study, but in general they tended to be older and the range of final diagnoses was much wider. There were 73 deaths in hospital within this group.
Twenty four of the 29 patients with chest pain without a known cause underwent exercise testing and there was only one positive result. This patient developed 2 mm ST segment depression in leads V4-V5 during stage IV ofthe Bruce protocol that was not associated with chest pain; she remained pain free and event free for the whole of the three year follow up. The five patients who did not undergo an exercise test were unable or unwilling to walk on the treadmill. Over three years, within the whole group, there was only one cardiac event, a non-fatal infarction. This patient had undergone exercise testing after his index admission, during which he had reached stage V without chest pain or electrocardiographic changes and he had a normal blood pressure response. After three years, three of the remaining 27 had angina as indicated by a positive Rose questionnaire.
PATIENTS WITH UNSTABLE ANGINA
Eight of the patients with unstable angina were admitted twice during the six month study period, but survival data were only analysed for the first admission. One hundred and forty one patients with unstable angina therefore formed the basis of this study. These patients were divided into the three groups defined above: 35 patients gave a history of effort related angina as defined by a positive Rose questionnaire, but had no electrocardiographic abnormalities at any time (group 1), 39 patients had a documented previous myocardial infarction, but no new electrocardiographic changes (group 2), and in 67 there were transient ST-T wave changes accompanying pain (group 3). Thirty eight patients in group 3 had had a previous myocardial infarction as well as transient ischaemic changes.
Pre-admission characteristics Table 2 shows the age, sex, smoking habit, and frequency of previous myocardial infarction in the three groups of patients with unstable angina. Table 3 shows the characteristics of the anginal pain of these patients during the four weeks before admission. Symptoms of worsening angina were equally common in the three groups, and no featues in the history served to distinguish them.
Early complications There were three deaths in hospital in the unstable angina group (at days 7, 9, and 24), each resulting from myocardial infarction and giving a mortality of 2% in hospital. The carfdoT patients (sensitivity 62%, specificity 49%, positive predictive accuracy 15%). Selecting h osp-patients with more than five attacks of pain in rises in hospital identified 18 patients in whom four infarc-events occurred (sensitivity 31%, specificity it were 85%, positive predictive accuracy 22%).
rs) and Three year follow up Figure 2 shows the long term event free survival curves for the patients with chest pain without a known cause and for those in the three different categories of unstable angina. (23) 18 (27) Non-cardiac death (angina only) had a similar survival pattern to patients with chest pain without a known cause. After three years, 16 (46%) of those who had been admitted with angina still had this complaint, but 13 (37%) were completely free both of events and angina. In groups 2 and 3, the initial high event rate in the first two months decreased, but events continued to occur over the whole three year peiod. Only eight (21 %) of the 39 patients who had had a previous infarction (group 2) and 15 (22%) of the 67 patients with reversible ST-T changes (group 3) remained free of symptoms and events after three years. The groups with continued complications tended to be older (mean of 61 v 58 years) although this did not achieve statistical significance (p = 0 11). Comparisons between the cardiovascular event rates which we found and other published data are difficult because of differences with case selection, and because different durations of follow up have been described. In a community study of patients, not in hospital, with recent onset or worsening of pre-existing angina, the one month and six month cardiac event rates (fatal and non-fatal infarction combined) were 7% and 13%1428 In studies of patients with unstable angina who were admitted to hospital, the rate of fatalities in hospital varied between 1 and 8%, whereas the one year fatality rate was 10-18%. The event rate one month after admission was between 9 and 130/. 8 9 11 15 Control groups from trials of drug treatments give a clearer view of the importance of case selection. In the Canadian study of aspirin and sulphinpyrazone, patients were included if they had a positive Rose questionnaire or transient electrocardiographic changes with pain.' After a mean of 18 months, the event rate in the placebo group was 17% with 11-7% deaths. In the Veterans' Administration study of aspirin, entry to the study depended mainly on the patients' history with some more definitive evidence of underlying coronary disease. 2 The event rate at three months was 10-1% with 3-3% deaths. In the ticlopidine study, which included patients with an appropriate history and transient electrocardiographic changes, the event rate at six months in the control group was 13-6% with 4*7% deaths.'9 These results can be compared with our rate of event at two months of 9% of all patients with unstable angina, 10% in those with a previous infarction, and 13% in those with transient electrocardiographic changes. The relatively low event rate in the Veterans' Administration trial probably reflects the inclusion of cases we have identified as low risk,2 whereas the patients admitted to the ticlopidine trial were comparable with our high risk group.
Our findings suggest that once two months have elapsed the risk diminishes and is probably similar to that of patients who have survived a myocardial infarction for a similar time. The three year mortality of 25% in our groups 2 and 3 compares with 33% in infarct survivors reported by Norris et al. 29 Our early event rate within the first two months in these groups should also be compared with those shown to have had a myocardial infarction. In second international study of infarct survival (ISIS-2),'3 Gruppo Italiano per lo Studio della Streptochinasi nell'Infarcto Miocardico (GISSI)," and Anglo-Scandinavian study of early thrombosis (ASSET)"2 mortality in the placebo group at one month ranged from 9-8% to 13%; the proportion eventually shown to have a myocardial infarction being variable. At six months 13*1% of the placebo group in ASSET had died (17-1% of those with a definite infarction); at one year 18% of the placebo group in ISIS 2 and 19% of those in GISSI had died. In all ofthese studies the nonfatal reinfarction rate was low at 3 or 4% in the first month, and up to 6 or 7% in the first six months. Our hospital death mortality rate of 13% for patients with acute infarction is therefore what would have been expected in the pre-thrombolytic era, and this event rate should be compared with the hospital mortality rate of 3%, a mortality rate at two months of 7*5%, and the three year mortality rate of 25% for the 106 patients in groups 2 and 3. In these patients the non-fatal reinfarction rate was 5% at two months.
If we include patients who are admitted to a coronary care unit because of a history suggestive of prolonged ischaemia at rest but who have no other evidence of coronary disease, (chest pain without a known cause group), the outlook is clearly better than it is for patients with myocardial infarction. Patients with only a positive Rose questionnaire as a means of making the diagnosis (our group 1) also have an excellent prognosis so there are high and low risk groups within the overall category of unstable angina. Severi et al found," as we did, that patients in whom the diagnosis was made simply on the basis of history had an excellent prognosis, and they showed that the subsequent positive exercise test had little relation to the outcome. Heart failure (defined as an increased cardiothoracic ratio'°1 or raised left ventricular end diastolic pressure5) identified a higher risk group in some but not all studies.8
Recurrence of pain' 15 and electrocardiographic changes21012 1 going to be extremely difficult to establish whether coronary angiography, percutaneous transluminal coronary angioplasty, or coronary artery bypass will reduce the risk of cardiac death or non-fatal infarction in these patients. The morbidity of the condition is substantial, with only a minority of patients remaining event free and free from angina at three years, so a study that included chronic angina as an undesirable outcome would be more feasible.
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